Founder and Managing Partner, Frazier Healthcare Ventures
Director, Life Sciences Institute, University of Michigan
Managing director, the Foundry Group
Medical College of Wisconsin director of research commercialization
Co-Founder and CEO, Wetpaint
Managing Director, D.E. Shaw and Co., L.P.
Founder, Young Inventors
Software Engineer at Skelmir
GlaxoSmithKline has written Lexington, MA-based Synta Pharmaceuticals (NASDAQ: SNTA) a check for $80 million. The payment is the first installment under a cancer-drug development agreement that could ultimately be worth $1.1 billion for the Lexington firm.
Xconomy Insight · Special Report
Success or failure depends on you. Get advice from the experts to help your startup succeed
From Our Editors · Video
Video interview with David Berry, general partner at Flagship Pioneering.
Providence Ventures shares its advice on making successful invest
Providence Ventures
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
